Skip to NavigationSkip to content

New York

Hydroxychloroquine given to 1,100 patients with COVID-19 in New York

Photo by ahundt

The malaria drug hydroxychloroquine is being administered to 1,100 patients in New York, which is fast becoming the new epicenter of the coronavirus pandemic.

The drug is being test on an experimental basis, and it is hoped by President Trump that it will become a treatment for the virus.

Regeneron invest $800 million into New York facilities

Regeneron is investing $800 million into its New York production facilities.

The firm is planning to build a four story Science Building containing labs and offices, and a six story car park with capacity for 1,020 cars, in the town of East Greenbush in New York State.

The new facility will bring 1,050 new workers to the town making it will be one of the region’s biggest employers. There will be around 4,000 and 5,000 Regeneron employees in East Greenbush overall.

New Yorkers must be vaccinated or face a fine

A public health emergency has been declared in New York following an outbreak of measles. Residents of certain postcodes in Brooklyn have thus been told to get vaccinated or face a fine.

There have been 285 cases of measles in the particular Brooklyn postcodes since the 30 September, 246 of which were in children, according to New York health commissioner Oxiris Barbot.

Of the 285 people who were infected with measles 21 were hospitalised while five were admitted into intensive care. However no-one has, as of yet, died.

Sacklers fraudulently transferred funds to dodge litigation, lawsuit says

New York state prosecutors have filed a lawsuit against members of the Sackler family, alleging the Purdue Pharma controllers fraudulently transferred hundreds of millions of dollars into offshore accounts, as part of an effort to protect their funds from litigation.

Measles outbreak spurs New York County to ban all unvaccinated children from public spaces

Rockland County, New York State, is taking serious measures to combat its biggest measles outbreak in decades, making the decision to ban all unvaccinated children from all public spaces.

The ban was announced alongside the declaration of a countywide state of emergency on 26 April, one that will remain in place for either 30 days or until unvaccinated children receive the measles, mumps and rubella (MMR) vaccine.

New York sues Purdue Pharma over opioid crisis

New York State have sued OxyContin drug maker Purdue Pharma over allegations surrounding widespread fraud and deception in the marketing of opioids.

Officials blamed the privately held pharmaceutical company for its role in fuelling the opioid crisis which has killed tens of thousands across the United States in recent years.

BMS restructure will transfer 90 jobs from NY state to Massachusetts and New Jersey

Bristol-Myers Squibb has announced plans to relocate around 90 roles from the state of New York to facilities in Massachusetts and New Jersey as part of a restructuring effort.

While the exact number of roles to be moved is still to be confirmed, the company’s pharmaceutical plant in DeWitt will see the loss of employees, transferred to Devens and Central New jersey, where the firm has several facilities.

New York in $500 million de Blasio-backed biotech boost

Mayor of New York, Bill de Blasio, has announced a $500 million initiative to drive the development of the biotech industry within the city. The initiative has been dubbed LifeSci NYC, with a major focus of the development being to build a new Applied Life Sciences Campus. The aim of this new space being to provide an area where Biotech startups can grow their company without needing to move away to more affordable or spacious areas in rival cities, such as Boston or San Francisco.

Roche unveils New York research base

Roche image

Roche is to locate a new translational clinical research centre in central New York, as part of a shift towards a more streamlined approach to R&D.

The company’s new Translational Clinical Research Center (TCRC) will be located at the Alexandria Center for Life Science on the East side of Manhattan, and will become operational from late 2013.

The centre will be the critical early development presence for Roche Pharma Research and Early Development (pRED), and will take over from Roche’s current US research base in Nutley, New Jersey.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches